Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

This study has been terminated.
(too slow patient recruitment)
Sponsor:
Information provided by (Responsible Party):
Valentin Fuhrmann, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01518595
First received: October 26, 2011
Last updated: September 27, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)